360 NEWS360 NEWS
Home / Healthcare

Gilead signs generic licensing deals for experimental Ebola drug

A late-stage trial is testing the drug in people at high risk after exposure. The deals are intended to line up manufacturing and supply before trial results and regulatory filings

Published
Original News Source The Hindu — Health
Source Website www.thehindu.com ↗
Content & Media Rights The Hindu — Health
Editorial Publisher 360 NEWS (Independent Media)
Gilead signs generic licensing deals for experimental Ebola drug
Photo / Source: The Hindu — Health
A late-stage trial is testing the drug in people at high risk after exposure. The deals are intended to line up manufacturing and supply before trial results and regulatory filings

Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].